MT1013 Injection

MT1013 · Shaanxi Micot Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MT1013 Injection, covering 2025-05-16 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: MT1013 Injection for the Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease [Phase 2]

See pricing